Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the anticoccidial drugs market right now?

The anticoccidial drugs market has experienced notable growth in recent years. It is expected to grow from $1.27 billion in 2024 to $1.37 billion in 2025, at a compound annual growth rate (CAGR) of 7.6%. This growth is attributed to the rising incidence of coccidiosis globally, an increase in pet ownership, the widespread prevalence of coccidiosis, its economic impact, and heightened safety concerns regarding food and animal health.

How fast Is the anticoccidial drugs market expected to grow, and what’s its future value?

The anticoccidial drugs market is expected to grow rapidly, reaching $1.81 billion by 2029 with a CAGR of 7.2%. Factors driving this growth include increasing veterinary healthcare, the rise in coccidiosis among animals, growing demand for synthetic drugs, feed additives, and higher livestock production. Trends include higher demand due to emerging coccidiosis strains, a shift to natural treatments, innovation prompted by regulatory scrutiny, rising demand for antibiotic-free poultry, advancements in drug delivery, and growing use in aquaculture and companion animals.

Get your anticoccidial drugs market report here!

https://www.thebusinessresearchcompany.com/report/anticoccidial-drugs-global-market-report

What are the leading drivers of growth in the anticoccidial drugs market?

The growing demand for meat proteins is expected to drive the growth of the anticoccidial drug market. The rising demand for meat proteins, driven by population growth, increasing disposable income, urbanization, and dietary changes, requires efficient and sustainable farming methods. Anticoccidial drugs are used in livestock farming to maintain animal health and productivity, preventing diseases like coccidiosis. In 2022, global meat prices surged by 10%, reflecting the increased demand for meat proteins, which is driving the growth of the anticoccidial drug market.

What are the key segments defining the anticoccidial drugs market?

The anticoccidial drugs market covered in this report is segmented –

1) By Drug Class: Ionophore, Antibiotic, Sulphonamides, Chemical Derivative, Other Drug Classes

2) By Drug Action: Coccidiostatic, Coccidiocidal

3) By Application: Poultry, Swine, Fish, Cattle, Companion Animals

4) By Distribution Channel: Veterinary Hospitals, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Ionophore: Monensin, Lasalocid, Salinomycin

2) By Antibiotic: Tylosin, Lincomycin, Bacitracin

3) By Sulphonamides: Sulfadimethoxine, Sulfaquinoxaline

4) By Chemical Derivative: Diclazuril, Clopidol

5) By Other Drug Classes: Amprolium, Robenidine

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15723&type=smp

Who are the key players steering the development of the anticoccidial drugs market?

Major companies operating in the anticoccidial drugs market are Johnson & Johnson, Merck and Co. Inc., Bayer AG, Novartis AG, Eli Lilly and Company Ltd., Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Santé Animale S.A., Virbac S.A., Phibro Animal Health Corporation, Vetoquinol SA, Alpharma BVBA, Kepro B.V., Kemin Industries Inc., Tianjin Ringpu Bio-Technology Co. Ltd., Hester Biosciences Limited, Huvepharma AD, Biovet S.A., Lallemand Animal Nutrition, HIPRA, Impextraco NV, Venkateshwara Hatcheries Pvt Ltd

What emerging trends are influencing the growth of the anticoccidial drugs market?

Companies in the anticoccidial drugs market are introducing new solutions, such as synthetic coccidiostat, to combat coccidiosis in poultry. For instance, in March 2023, Zoetis launched Avi-Deccox, a reformulated synthetic coccidiostat designed to effectively control coccidiosis in broiler chickens. It addresses resistance issues associated with ionophores and targets specific pathogens responsible for economic losses in poultry farming.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15723

Which regions are most influential in expanding the anticoccidial drugs market?

North America was the largest region in the anticoccidial drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anticoccidial drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Ovarian Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ovarian-cancer-drugs-global-market-report

Kidney Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/kidney-cancer-drugs-global-market-report

Prostate Cancer Drugs Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/prostate-cancer-drugs-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: